TrialNet Pathway to Prevention of T1D

RecruitingOBSERVATIONAL
Enrollment

75,000

Participants

Timeline

Start Date

February 1, 2004

Primary Completion Date

July 31, 2030

Study Completion Date

July 31, 2030

Conditions
Diabetes Mellitus, Type 1
Trial Locations (22)

3050

RECRUITING

Walter and Eliza Hall Institute, Parkville

10032

RECRUITING

Columbia University, New York

15213

RECRUITING

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

30322

RECRUITING

Emory Children's Center, Atlanta

37232

RECRUITING

Vanderbilt University, Nashville

46202

RECRUITING

Riley Hospital for Children, Indiana University, Indianapolis

58944

RECRUITING

University of Minnesota, Minneapolis

64111

RECRUITING

The Children's Mercy Hospital, Kansas City

77030

RECRUITING

Baylor College of Medicine, Houston

80262

RECRUITING

Barbara Davis Center for Childhood Diabetes, Denver

92868

RECRUITING

Childrens Hospital of Orange County, Orange

94143-0434

RECRUITING

University of California San Francisco, San Francisco

94305-5208

RECRUITING

Stanford University Medical Center, Stanford

06519

RECRUITING

Yale University School of Medicine, New Haven

32601-0296

RECRUITING

University of Florida, Gainesville

02215

RECRUITING

Joslin Diabetes Center, Boston

75390-8858

RECRUITING

University of Texas Medical Center at Dallas, Dallas

98101-2795

RECRUITING

Benaroya Research Institute, Seattle

M5G-1x8

RECRUITING

The Hospital for Sick Children, Toronto

FIN-20520

SUSPENDED

University of Turku, Turku

+39-02-2643 2818

SUSPENDED

Vita-Salute San Raffaele University, Milan

BS10 5NB UK

SUSPENDED

University of Bristol, Bristol

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

American Diabetes Association

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

University of South Florida

OTHER